Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Sterling to invest $1.5 million in its new North Carolina facility

by Rick Mullin
November 2, 2019 | A version of this story appeared in Volume 97, Issue 43

Sterling Pharma Solutions will spend $1.5 million to expand its recently acquired facility in Cary, North Carolina. The British firm plans over the next 3 years to add current good manufacturing practice (cGMP)-certified production suites for active pharmaceutical ingredients as well as non-cGMP scale-up capacity. Sterling will also expand research and quality control facilities. Sterling, which acquired the site from CiVentiChem last year, notes that 70% of its customers are in North America.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.